The weekly litigation news digest is live. Subscribe now

IP Verse

Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof

Patent No. EP3590949 (titled "Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses Thereof") was filed by Moderna on Oct 3, 2011. The application was issued on May 18, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ETHERNA IMMUNOTHERAPIESFeb 20, 2023ARNOLD & SIEDSMA
MAIWALDFeb 20, 2023MAIWALD
GLAXOSMITHKLINEFeb 17, 2023RAVASIO
PFIZERFeb 17, 2023DORRIES
PFIZERFeb 17, 2023DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN
WITHERS & ROGERSFeb 17, 2023GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
KILBURN & STRODEFeb 17, 2023KILBURN & STRODE
SANOFIOct 5, 2022CARPMAELS & RANSFORD
PATENT BOUTIQUESep 27, 2022PATENT BOUTIQUE
BIONTECHSep 23, 2022WILK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3590949

MODERNA
Application Number
EP19177059A
Filing Date
Oct 3, 2011
Status
Granted And Under Opposition
Apr 15, 2022
Publication Date
May 18, 2022
External Links
Slate, EP3590949B1, Google Patents